Le Lézard
Classified in: Health
Subjects: PDT, SCZ

Centre for Aging + Brain Health Innovation accelerates development and testing of new Quebec-based healthcare innovations for older adults


MONTRÉAL, Aug. 13, 2019 /CNW/ - The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, in collaboration with four academic centres in Quebec, announced support for the validation testing of two new healthcare innovations for older adults, specifically for those living with dementia.

The innovations received support through CABHI's Quebec Researcher-Clinician Partnership Program (QRCP2), in partnership with four Quebec-based academic centres: the RUIS McGill Centre of Excellence on Longevity (CIUSSS West-Central Montreal), Institut universitaire de gériatrie de Montréal (CIUSSS du Centre-Sud de l'Île-de-Montréal), Centre de recherche sur le vieillissement (CIUSSS Estrie-CHUS), and Centre d'excellence sur le vieillissement (CIUSSS de la Capitale-Nationale).

QRCP2 supports teams of clinicians and researchers collaborating to refine, test, validate and disseminate innovations at an advanced stage of development. Funded projects evaluate the application and impact of the innovation in real-world seniors' care settings, going beyond lab tests and other tightly controlled test environments.

The supported innovations are:

"CABHI's programs and services empower innovators to venture beyond the lab and test their solutions in real-world settings," said Dr. Allison Sekuler, Managing Director for CABHI, Sandra A. Rotman Chair in Cognitive Neuroscience, and Vice-President of Research at Baycrest. "Through CABHI's strong network of provincial partnerships, we fund projects from coast to coast ? getting much-needed innovations into the hands of folks who require them across the country. We're looking forward to seeing these projects make a real difference in the lives of older adults, their families and their caregivers in Quebec."

"The partnership with CABHI and the four Quebec-based academic centres has helped to accelerate the pace of innovation in our province and beyond. Through the QRCP2, two teams of researchers and clinicians in Quebec are given an opportunity to test, validate and refine their innovations for the benefit of the aging population," said Dr. Olivier Beauchet, Director of the RUIS McGill Centre of Excellence on Longevity, Geriatrician at the Jewish General Hospital, Professor at McGill University and the Joseph Kaufmann Chair in Geriatric Medicine.

About the Centre for Aging + Brain Health Innovation (CABHI)

About the RUIS McGill Centre of Excellence on Longevity

About the Centre de Recherche de l'Institut universitaire de gériatrie de Montréal

About the Centre de recherche sur le vieillissement de Sherbrooke

About the Centre d'excellence sur le vieillissement de Québec

SOURCE Baycrest Centre for Geriatric Care


These press releases may also interest you

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...



News published on and distributed by: